FLUDAMAX 50MG

Fludamax 50mg Injection is a chemotherapy drug that contains fludarabine as its active ingredient. It is indicated for the treatment of B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is a type of cancer affecting white blood cells, which are crucial for fighting diseases. In this condition, the body produces an excess of abnormal white blood cells, leading to the enlargement of lymph nodes in various areas of the body. This can result in organ failure, a reduction in red blood cells, severe bleeding, and increased susceptibility to infections.

Fludamax 50mg Injection is not advised for use in adolescents and children under 18 years, nursing mothers, or individuals with severe kidney issues or low red blood cell counts. It is essential to employ effective birth control methods during treatment with this medication and for at least six months following the final dose. Live vaccinations should be avoided while on this medication. If you notice any allergic reactions while using Fludamax 50mg Injection, please inform your doctor immediately.